Immunotherapy of renal cell cancer
โ
Richard Crusinberry; Richard D. Williams
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 778 KB
Immunotherapy of metastatic renal adenocarcinoma (RCC) is currently an alternative to cytotoxic chemotherapy. Bacillus Calmette-GuCrin has been associated with a 22% response rate in small series, but no large-scale clinical trials have been completed. Transfer factor, in combination with other immu